These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differences between plasma and synovial fluid fibronectin. Scott DL, Carter SD, Coppock JS, Robinson M, Walton KW. Rheumatol Int; 1985 Jun; 5(2):49-54. PubMed ID: 3885371 [Abstract] [Full Text] [Related]
3. Identification of citrullinated cellular fibronectin in synovial fluid from patients with rheumatoid arthritis. Kimura E, Kanzaki T, Tahara K, Hayashi H, Hashimoto S, Suzuki A, Yamada R, Yamamoto K, Sawada T. Mod Rheumatol; 2014 Sep; 24(5):766-9. PubMed ID: 24498912 [Abstract] [Full Text] [Related]
4. Synovial fluid and plasma fibronectin levels in rheumatoid arthritis. Scott DL, Farr M, Crockson AP, Walton KW. Clin Sci (Lond); 1982 Jan; 62(1):71-6. PubMed ID: 7056032 [Abstract] [Full Text] [Related]
5. Different synovial fluid fibronectin levels in rheumatoid variants. Goebel KM, Storck U, Krüger K, Schattenkirchner M. Klin Wochenschr; 1984 Aug 16; 62(16):768-72. PubMed ID: 6482313 [Abstract] [Full Text] [Related]
6. Enhanced expression of a peanut agglutinin reactive O linked oligosaccharide on fibronectins from the synovial fluid of patients with rheumatic disease: quantitation, domain localization, and functional significance. Carsons S. J Rheumatol; 2002 May 16; 29(5):896-902. PubMed ID: 12022346 [Abstract] [Full Text] [Related]
7. Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Vartio T, Vaheri A, Von Essen R, Isomäki H, Stenman S. Eur J Clin Invest; 1981 Jun 16; 11(3):207-12. PubMed ID: 6791940 [Abstract] [Full Text] [Related]
8. Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Carnemolla B, Cutolo M, Castellani P, Balza E, Raffanti S, Zardi L. Arthritis Rheum; 1984 Aug 16; 27(8):913-21. PubMed ID: 6466396 [Abstract] [Full Text] [Related]
9. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma. Carsons SE, Schwartzman S, Diamond HS, Berkowitz E. Clin Exp Immunol; 1988 Apr 16; 72(1):37-42. PubMed ID: 3135129 [Abstract] [Full Text] [Related]
10. Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Scott DL, Wainwright AC, Walton KW, Williamson N. Ann Rheum Dis; 1981 Apr 16; 40(2):142-53. PubMed ID: 7013719 [Abstract] [Full Text] [Related]
11. Different molecular forms of fibronectin in rheumatoid synovial fluid. Clemmensen I, Andersen RB. Arthritis Rheum; 1982 Jan 16; 25(1):25-31. PubMed ID: 7066034 [Abstract] [Full Text] [Related]
13. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE. Arthritis Rheum; 2001 Jul 16; 44(7):1568-81. PubMed ID: 11465708 [Abstract] [Full Text] [Related]
14. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Conway EM, Nowakowski B. Blood; 1993 Feb 01; 81(3):726-33. PubMed ID: 7678998 [Abstract] [Full Text] [Related]
20. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis. Peters JH, Carsons S, Yoshida M, Ko F, McDougall S, Loredo GA, Hahn TJ. Arthritis Res Ther; 2003 Sep 15; 5(6):R329-39. PubMed ID: 14680507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]